BLXA4

Generic Name: BLXA4

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₃₂O_₅

CAS Number: 864516-86-9

Unique Ingredient Identifier: LXE89WJ787

Background: BLXA4 has been used in trials studying the treatment of Gingival Inflammation.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Safety and Preliminary Efficacy of Lipoxin Analog BLXA4-ME Oral Rinse for the Treatment of Gingivitis

Phase 1

Completed

Conditions: Gingival Inflammation

Interventions: Drug: Placebo oral rinse
Drug: BLXA4

First Posted Date: 2015-01-21

Last Posted Date: 2023-12-20

Lead Sponsor: The Forsyth Institute

Target Recruit Count: 127

Registration Number: NCT02342691

Locations: 🇺🇸
The Forsyth Institute, Cambridge, Massachusetts, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy